Archives for July 2, 2007

← 2007

Ablynx technology rivals GSK's mini-antibodies

By  Mike Nagle

Belgian biopharma Ablynx has announced its lead miniature antibody has shown good interim results in a first-in-man trial, leaving it one step ahead of GlaxoSmithKline (GSK).

BioAlliance's buccal tab brings in the cash

By  Anna Lewcock

A novel antifungal treatment developed by French firm BioAlliance has attracted a US partner, bringing $65m (€48m) to the company only months after announcing a multi-million deal in Europe.

NextPharma moves forward with funds and acquisition

By  Emilie Reymond

British contract manufacturing organisation (CMO) NextPharma Technologies has announced a €30m fundraising round and the acquisition of Bioserv, another CMO based in the US.

Sartorius Stedim Biotech born

By  Anna Lewcock

The hook-up between German and French firms Sartorius and Stedim to create a combined biotech business is now complete, with the deal finalised and the new company ready to roll.

Amaxa drives high-throughput cell transfection

By  Dr Matt Wilkinson

The European Commission (EC) has given a €2.75m grant to a consortium of companies, led by Amaxa, to develop the first ultra high-throughput (UHT) devices for transfecting cells.

Thar expands SFC business with Berger acquisition

By  Dr Matt Wilkinson

Thar Instruments has bought Berger SFC from Mettler Toledo to expand its SFC capabilities and achieve 'critical mass' in a market that is growing as pharma looks for greener separation options.

Top CSOs jostle for UK dominance

By  Kirsty Barnes

Two of the UK's top contract sales organisations (CSO) have merged to create what is claimed to be the country's leading CSO - something that is disputed by its nearest rival.

Pharmanet reaches turning point in Phase I biz

By  Kirsty Barnes

PharmaNet Development Group has reached a significant turning point in its attempt to finally close the doors on a long period of trouble with its Phase I clinical business.

eClinical news in brief

By  Emilie Reymond

Outsourcing-Pharma tracks the latest eClinical movements, featuring Chiltern, ClinPhone, Medidata Solutions, ClearTrial, and Phase Forward.

EU approves recombinant fertility drug duo

By  Kirsty Barnes

A new recombinant combo treatment that could help some of the rising number of women experiencing fertility problems, has now been approved for use in the Europe.

Systech upgrades packaging software

By  Katrina Megget

US-based Systech International has enhanced its features to its packaging software application, Systech Guardian.